Evaluation of TCR-pMHC Affinity and its Implications for T Cell Therapies with Immudex & Quality Assistance
Webinar Recording & Slide Deck
By filling out this form, you can access the webinar recording and the slide deck.
This webinar covers:
- Challenges associated with production of high quality TCR monomers suitable for TCR affinity measurement
- The importance of TCR affinity measurement in the context of development of T cell therapies
- Introduction to two techniques used for affinity measurement: Surface Plasmon Resonance and Biolayer Interferometry, and the advantages/disadvantages of each technique
- Results of a case study investigating the interaction between a modified affinity-enhanced TCR targeting the NY-ESO I antigen and its cognate pMHC (HLA-A*0201 / SLLMWITQC) in terms of affinity and kinetics
- Recommendations on best practices for TCR-pMHC affinity measurement
Speakers:
- Lyn Zhu - R&D Scientist, Immudex
- Fabian Vandermeers - R&D Technical Leader, Quality Assistance